Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humans

Brian Schmidt, Robert W. Gear, Jon D. Levine

Research output: Contribution to journalArticle

Abstract

We report on the response of medically refractory neuropathic trigeminal pain in three patients to intravenous administration of a combination of the kappa-partial agonist opioid nalbuphine and the opioid antagonist naloxone. Each of the three patients had developed a painful peripheral neuropathy as a complication of chemical or mechanical injury to the trigeminal nerve. Each patient had been tried on a number of analgesics, including mu-opioids, and had not gained relief or was not able to tolerate side effects of the medications. Pain intensity was measured for 3 h following drug administration using a 10 cm visual analog scale. All three patients reported marked decrease in pain following administration of the nalbuphine and naloxone combination. These findings suggest a novel approach to the management for neuropathic pain.

Original languageEnglish (US)
Pages (from-to)144-146
Number of pages3
JournalNeuroscience Letters
Volume343
Issue number2
DOIs
StatePublished - Jun 5 2003

Fingerprint

Nalbuphine
Neuralgia
Naloxone
Opioid Analgesics
Trigeminal Nerve Injuries
Pain
Intractable Pain
Narcotic Antagonists
Peripheral Nervous System Diseases
Visual Analog Scale
Intravenous Administration
Analgesics
Pharmaceutical Preparations

Keywords

  • Anti-analgesia
  • Dysesthesia
  • Kappa opioids
  • Local anesthetic toxicity
  • Nerve injury
  • Opioid antagonism

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humans. / Schmidt, Brian; Gear, Robert W.; Levine, Jon D.

In: Neuroscience Letters, Vol. 343, No. 2, 05.06.2003, p. 144-146.

Research output: Contribution to journalArticle

@article{a33f56b1ae0d4a6aa105bc5266568ece,
title = "Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humans",
abstract = "We report on the response of medically refractory neuropathic trigeminal pain in three patients to intravenous administration of a combination of the kappa-partial agonist opioid nalbuphine and the opioid antagonist naloxone. Each of the three patients had developed a painful peripheral neuropathy as a complication of chemical or mechanical injury to the trigeminal nerve. Each patient had been tried on a number of analgesics, including mu-opioids, and had not gained relief or was not able to tolerate side effects of the medications. Pain intensity was measured for 3 h following drug administration using a 10 cm visual analog scale. All three patients reported marked decrease in pain following administration of the nalbuphine and naloxone combination. These findings suggest a novel approach to the management for neuropathic pain.",
keywords = "Anti-analgesia, Dysesthesia, Kappa opioids, Local anesthetic toxicity, Nerve injury, Opioid antagonism",
author = "Brian Schmidt and Gear, {Robert W.} and Levine, {Jon D.}",
year = "2003",
month = "6",
day = "5",
doi = "10.1016/S0304-3940(03)00356-2",
language = "English (US)",
volume = "343",
pages = "144--146",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humans

AU - Schmidt, Brian

AU - Gear, Robert W.

AU - Levine, Jon D.

PY - 2003/6/5

Y1 - 2003/6/5

N2 - We report on the response of medically refractory neuropathic trigeminal pain in three patients to intravenous administration of a combination of the kappa-partial agonist opioid nalbuphine and the opioid antagonist naloxone. Each of the three patients had developed a painful peripheral neuropathy as a complication of chemical or mechanical injury to the trigeminal nerve. Each patient had been tried on a number of analgesics, including mu-opioids, and had not gained relief or was not able to tolerate side effects of the medications. Pain intensity was measured for 3 h following drug administration using a 10 cm visual analog scale. All three patients reported marked decrease in pain following administration of the nalbuphine and naloxone combination. These findings suggest a novel approach to the management for neuropathic pain.

AB - We report on the response of medically refractory neuropathic trigeminal pain in three patients to intravenous administration of a combination of the kappa-partial agonist opioid nalbuphine and the opioid antagonist naloxone. Each of the three patients had developed a painful peripheral neuropathy as a complication of chemical or mechanical injury to the trigeminal nerve. Each patient had been tried on a number of analgesics, including mu-opioids, and had not gained relief or was not able to tolerate side effects of the medications. Pain intensity was measured for 3 h following drug administration using a 10 cm visual analog scale. All three patients reported marked decrease in pain following administration of the nalbuphine and naloxone combination. These findings suggest a novel approach to the management for neuropathic pain.

KW - Anti-analgesia

KW - Dysesthesia

KW - Kappa opioids

KW - Local anesthetic toxicity

KW - Nerve injury

KW - Opioid antagonism

UR - http://www.scopus.com/inward/record.url?scp=0038662902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038662902&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(03)00356-2

DO - 10.1016/S0304-3940(03)00356-2

M3 - Article

VL - 343

SP - 144

EP - 146

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 2

ER -